Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Phase 3 Study of Agile Transdermal Contraceptive Delivery System (AG200-15) in Sexually Active Women Requesting Contraception
2011-000087-95Phase 3Completed
- Sponsor
- Agile Therapeutics
- Start
- May 2011
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, open-label, single-arm trial of ethinyl estradiol + levonorgestrel, sponsored by Agile Therapeutics. Primary endpoint: Pregnancy rates. Started May 2011; status: completed.
02
Drugs
ethinyl estradiol + levonorgestrel
Beyond the preview
Go deeper on 2011-000087-95.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2011-000087-95.